Skip to content

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising

Business

Novo asked the court to permanently stop Lilly from running the “deceptive” ads and require the drugmaker to issue corrective advertising.


Source: CNBC Top News — This article was automatically imported from the source. Read full article at original source →

CN
Originally published by CNBC Top News cnbc.com
Visit original article

admin

Leave a Comment